Table 4 Quality of life scores of SLE patients in control and therapy groups over time
Domain | Time | Control (n = 43) | Therapy (n = 37) | Inter-group P* |
|---|---|---|---|---|
Median (Min-Max) | Median (Min-Max) | |||
Physical function | T1 | 12.0 (6.0–34.0) | 10.0 (2.0–39.0) | 0.645 |
T2 | 14.0 (6.0–36.0) | 9.0 (6.0–30.0) | 0.023 | |
Intra-group P** | 0.245 | 0.057 | ||
Occupational activity | T1 | 24.0 (9.0–59.0) | 25.0 (1.0–59.0) | 0.743 |
T2 | 31.0 (9.0–61.0) | 17.0 (9.0–42.0) | 0.001 | |
Intra-group P** | 0.055 | 0.001 | ||
Symptoms | T1 | 22.0 (8.0–49.0) | 23.0 (6.0–51.0) | 0.589 |
T2 | 25.0 (8.0–46.0) | 14.0 (8.0–37.0) | 0.001 | |
Intra-group P** | 0.023 | < 0.001 | ||
Treatment | T1 | 11.0 (4.0–22.0) | 10.0 (3.0–19.0) | 0.591 |
T2 | 11.0 (4.0–25.0) | 8.0 (1.0–20.0) | 0.002 | |
Intra-group P** | 0.093 | 0.008 | ||
Humor | T1 | 14.0 (4.0–28.0) | 15.0 (4.0–28.0) | 0.376 |
T2 | 13.0 (4.0–28.0) | 9.0 (4.0–26.0) | 0.005 | |
Intra-group P** | 0.321 | < 0.001 | ||
Self-Image | T1 | 20.0 (9.0–51.0) | 25.0 (9.0–53.0) | 0.178 |
T2 | 20.0 (9.0–54.0) | 15.0 (9.0–33.0) | 0.003 | |
Intra-group P** | 0.764 | < 0.001 | ||
Total score | T1 | 114.0 (40.0–204.0) | 109.0 (44.0–226.0) | 0.596 |
T2 | 113.0 (45.0–236.0) | 71.0 (40.0–153.0) | < 0.001 | |
Intra-group P** | 0.041 |